A Study of Teduglutide (Revestive®) in Children, Teenagers and Adults With Short Bowel Disease

Clinical trial NCT04877431 · COMPLETED

Trial details

NCT number: NCT04877431
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Short Bowel Syndrome

Start date: 2020-11-05
Primary completion: 2023-06-05
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.